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Abstract
Background: Despite evidence that physical activity improves the health and well-being of prostate cancer
survivors, many men do not engage in sufficient levels of activity. The primary aim of this study (ENGAGE) is to
determine the efficacy of a referral and physical activity program among survivors of prostate cancer, in terms of
increasing participation in physical activity. Secondary aims are to determine the effects of the physical activity
program on psychological well-being, quality of life and objective physical functioning. The influence of individual
and environmental mediators on participation in physical activity will also be determined.
Methods/Design: This study is a cluster randomised controlled trial. Clinicians of prostate cancer survivors will be
randomised into either the intervention or control condition. Clinicians in the intervention condition will refer
eligible patients (n = 110) to participate in an exercise program, comprising 12 weeks of supervised exercise
sessions and unsupervised physical activity. Clinicians allocated to the control condition will provide usual care to
eligible patients (n = 110), which does not involve the recommendation of the physical activity program.
Participants will be assessed at baseline, 12 weeks, 6 months, and 12 months on physical activity, quality of life,
anxiety, depression, self-efficacy, outcome expectations, goals, and socio-structural factors.
Discussion: The findings of this study have implications for clinicians and patients with different cancer types or other
chronic health conditions. It will contribute to our understanding on the potential impact of clinicians promoting
physical activity to patients and the long term health benefits of participating in physical activity programs.
Trial registration: Australia and New Zealand Clinical Trials Register (ANZCTR): ACTRN12610000609055
Deakin University Human Research Ethics Approval 2011-085
Background
Worldwide, prostate cancer is the second most common
cancer in men. In 2008, 899,120 cases of prostate cancer
were recorded, which represents 13.6 per cent of all new
cancer cases in men. In the same year, 258,133 deaths
were attributable to prostate cancer. It is predicted that
the number of cases will almost double (1.7 million) by
2030 [1].
Prostate cancer is the most commonly diagnosed can-
cer in Australia and has the third highest mortality rate
after lung and bowel cancers [2]. In 2007, 19,403 new
cases of prostate cancer were diagnosed and there were
2,938 deaths. The rate of prostate cancer increases
rapidly from the age of 45 years [2]. Improvements in
five-year survival rates have been observed for prostate
cancer, from 57% to 85% [3].
With improved survival rates, cancer survivors can
derive substantial functional, physical, and psychological
benefits from physical activity [4]. In men with prostate
cancer, systematic review evidence suggests that physical
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ity of life, muscular fitness, and physical functioning, as
well as reduce fatigue [5]. Although these findings are
promising, additional studies (especially randomised
controlled trials in cancer types other than breast can-
cer) need to be conducted to substantiate the work in
this area [4].
For prostate cancer survivors who have been treated
with androgen deprivation therapy (ADT), there may be
additional reasons to undertake physical activity. Previous
research has shown that after 36 weeks of ADT prostate
cancer patients decreased whole body lean mass by 2.4%,
bone mineral content and density of 2.4%, serum testos-
terone of 93.3%, PSA levels of 98.2%, and haemoglobin
levels of 8.8%, as well as increases in fat mass of 13.8%
[6]. Assisting men who are receiving ADT to become
physically active is, therefore, necessary to reduce the risk
of obesity, osteoporosis and sarcopenia.
Many men reduce their involvement in physical activ-
ity following a diagnosis of prostate cancer [7]. Although
evidence is mounting on the benefits of regular physical
activity for prostate cancer survivors, the prevalence of
physical activity among this group is modest and varies
widely between studies [5]. To improve the uptake of
physical activity among prostate cancer survivors, strate-
gies need to be developed and tested for their
effectiveness.
Research has highlighted gaps in information provi-
sion regarding the type and amount of physical activity
that prostate cancer survivors should undertake [8]. A
key challenge is to make such information accessible to
all prostate cancer survivors. One way in which this
information may be conveyed is via clinicians with refer-
rals to accredited exercise physiologists. However,
research has shown that most prostate cancer survivors
do not recall receiving information from clinicians about
integrating physical activity into their lives [8]. Patients
have reported clinicians are the most important con-
veyors of information [9] and a prescription or referral
to an exercise physiologist may be effective in promot-
ing physical activity among patients.
Evidence on the efficacy of prescriptions of physical
activity in general practice (GP) has been mixed [10-13].
In general, GP prescriptions of physical activity have led
t oam o d e r a t ei n c r e a s ei np h y s i c a la c t i v i t ya n df i t n e s s
levels for 6 to 12 months [14]. There have been few stu-
dies, however, on the efficacy of physical activity pre-
scriptions among people with specific chronic health
conditions and where physical activity prescriptions are
supplemented with other interventions, such as brief
counselling [11]. Findings from this limited research
have yielded less than optimal results. Overall however,
the findings of previous studies are sufficiently strong to
warrant further work in this area. The experience of
cancer may mean that survivors more readily comply
with the advice of their clinicians, which would result in
higher levels of physical activity from an intervention
that utilises clinician referral to an exercise physiologist
in this population.
Accredited exercise physiologists are specialists who
can provide prostate cancer survivors with expert advice
on how to increase their physical activity levels safely.
Since 2006 exercise physiologists accredited by Exercise
and Sport Science Australia (ESSA) have been part of
Australia’s universal healthcare system (Medicare). Med-
icare provides access to free or subsidised treatment
from medical practitioners, such as accredited exercise
physiologists. Given their place in the health system,
accredited exercise physiologists are well positioned to
make an important contribution to increasing the health
of prostate cancer survivors.
A criticism of previous randomised controlled trials
that have examined physical activity in cancer survivor
populations is that they do not incorporate a theoretical
framework. Theoretical frameworks are necessary to
guide the development and evaluation of interventions
so that the mechanisms that change behaviour can be
understood and replicated in future interventions [15].
There are compelling reasons for using social cognitive
theory [16] to underpin a physical activity intervention
for prostate cancer survivors. First, recent research con-
ducted with (a) participants of similar ages to prostate
cancer survivors who are likely to participate in this
planned study [17], and (b) cancer patients [18] have
shown that social cognitive theory constructs explain
substantial amounts of variance in physical activity. For
example, in a study of middle-aged and young-old
adults, social cognitive theory constructs explained 71%
of the variance in physical activity [17]. Second, social
c o g n i t i v et h e o r yc o n s t r u c t sa r en o to n l yp r e d i c t i v eo f
health behaviours, but provide avenues for modifying
them [16,19].
The main determinants of health behaviour in social
cognitive theory are self-efficacy, outcome expectations,
goals, and socio-structural factors [19,20]. Self-efficacy is
central to this conceptual model, and “refers to beliefs
in one’s capabilities to organise and execute the courses
of action required to produce given attainments” (p. 3,
[19]). Distinctions can be drawn between various types
of self-efficacy, with task and self-regulatory (coping)
self-efficacy common in the exercise and physical activ-
ity literature [21]. Task self-efficacy refers to the belief
in one’s ability to perform a given motor skill success-
fully (e.g., walking briskly for 30 minutes), whereas self-
regulatory self-efficacy refers to one’s ability to perform
the skill under conditions that may be challenging to
successful performance (e.g., inclement weather,
tiredness).
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one’s behaviour [19]. These effects may be physical
(beneficial or detrimental), social (favourable or adverse),
or self-evaluative (positive or negative). Goals provide
guidance to, and incentives for, behaviour. In social cog-
nitive theory, goals are classified as being either proxi-
mal or distal [19]. Proximal goals are essentially
equivalent to intentions and guide current behaviours,
whereas distal goals orientate future behaviours. Socio-
structural factors are facilitators and impediments to
h e a l t h yb e h a v i o u r s .T h e s ef a c t o r sm a yb ep e r s o n a lo r
situational, or lie within the health system. Enhancing
physical activity-related self-efficacy in prostate cancer
survivors and assisting them to develop positive out-
come expectations, set beneficial goals, and reduce per-
ceived impediments may result in higher physical
activity levels.
Our pilot work indicated that outcome expectations
for prostate cancer survivors to perform physical activity
reflected psychological and physical benefits that can be
attained through participation, as well as from the con-
text of activity, i.e. socio-structural factors, including
attractive locations, opportunities for spending time
alone, social interaction [8]. Conversely, impediments to
participation included limited confidence following
treatment, lack of time, co-morbidities, and age-related
functional decline. Despite the benefits of physical activ-
ity, men in this study did not recall receiving advice
from their clinicians about physical activity and few
reported being referred to exercise professionals. Given
these findings, interventions to increase physical activity
in prostate cancer survivors that incorporate referrals
from clinicians to exercise professionals and a well con-
structed theoretically tailored physical activity program
may achieve positive outcomes.
Study aims and hypotheses
The primary aim of the ENGAGE study is to compare
the efficacy of a clinician referral and 12-week, super-
vised, exercise physiologist-led physical activity program
compared to usual care (no referral to the physical
activity program and typically minimal advice about
physical activity) in improving the physical activity levels
of prostate cancer survivors at three post-intervention
time points:12 weeks, 6 months, 12 months. We
hypothesise that participants in the intervention condi-
tion will be more physically active than participants in
the control condition.
A secondary aim is to determine the effects of the clini-
cian referral and physical activity program on the psycho-
logical well-being, quality of life and objective physical
functioning of prostate cancer survivors. At the three
post-intervention time points (12 weeks, 6 months, 12
months), we hypothesise that the clinician referral and
physical activity program will improve participants’ quality
of life and decrease anxiety and depressive symptoms over
and above changes on such measures that participants in
the control condition may experience at post intervention.
We will measure objective physical functioning at baseline
and 12 weeks only, and hypothesise that participants in
the intervention condition will improve their exercise
capacity more than those in the control condition.
A further aim is to assess the impact of the interven-
tion on main health determinants using the social cogni-
tive theory and whether these determinants mediate
behaviour change. We hypothesise that the intervention
will have positive effects on self-efficacy, outcome expec-
tations, goals, and socio-structural factors; and that self-
efficacy will have a direct association with physical activ-
ity and an indirect association, mediated by outcome
expectations, goals, and socio-structural factors.
Methods
Design
This study is a cluster randomised controlled trial (RCT)
to test the efficacy of an intervention, i.e., a clinician’s
referral to a physical activity program, to generate a)
behaviour change (i.e., increasing physical activity levels)
that is sustained over time and b) improved psychologi-
cal well-being, quality of life, and objective physical
functioning outcomes among prostate cancer survivors.
The potential influence of individual and environmental
mediators on participation in physical activity will also
be determined.
Clinicians who agree to be involved in the study will
be randomized into the intervention or control condi-
tion prior to the commencement of the study via com-
puter-generated table of random numbers. Blinding of
the clinician is not possible in this study, as one of our
aims is to assess if the referral to the physical activity
program by clinicians’ influences the uptake of the phy-
sical activity program.
Our decision to undertake a cluster RCT, randomised
by clinician with no cross over, was one based on the
pragmatics of our situation. Our previous experience in
this field suggests that it is difficult to gain support from
busy clinicians if they were required to switch between
both experimental conditions in the recruitment of
patients [22]. Therefore, clinicians will be randomised
into one of the two conditions and patients of each clin-
ician will be regarded as separate clusters. There are
likely to be up to twelve clinicians involved in this study
(three clinicians from each of the three health services).
Although we anticipate the effect of variation in the
health services and in clinician physical activity recom-
mendations on the key outcomes of this research to be
very small, possible differences need to be taken into
account through the use of clustering [23].
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Eligible patients will be adult males who 1) have com-
pleted active treatment for prostate cancer within the
previous three-12 months. Participants currently on hor-
mone treatment will be eligible to participate; 2) were
treated with curative intent, representing stages I, II, or
III; and (3) have the ability to complete surveys in the
English language. Patients will be excluded from this
study if they have musculoskeletal, cardiovascular, or
n e u r o l o g i c a ld i s o r d e r st h a tc o u l dl i m i tt h e mf r o me x e r -
cising. The patients’ treating clinicians will assess their
eligibility for the study.
The sample size for this study was calculated based on
the primary research question; number of minutes of
moderate or strenuous physical activity in a typical week
in past month as measured by an adapted version of the
Leisure Time Exercise Questionnaire at the completion
of the 12 week intervention using the following assump-
tions: (1) a medium-sized effect will be found, (2) a will
be set at .05, (3) power will be set at .80, (4) the attrition
rate will be 10% at 12 weeks, and (5) the design effect
will be 1.084. The anticipated effect size was judged
from a similar project [24], where a medium-sized effect
was found for the outcome of a physical activity inter-
vention (d = 0.484), where the intervention group
increase their total weekly minutes of physical activity
by 59.3 minutes (SD = 126.6).
Physical activity levels will be measured at 12 weeks to
answer the primary research question. An attrition rate
of 10% is expected, based on our previous work in this
area [22]. A design effect of 1.084 was included to
account for clustering (ICC = .005, m¯¬ = 16.83). The
ICC was estimated from a recently completed study
investigating recruitment of newly diagnosed prostate
and colorectal cancer patients (clustered by specialist)
[22] and from published commentary in which the
authors suggested that ICC rates of less than 0.01 have
been found for practitioner prescribing rates [23]. The
average size of each cluster (m¯) was calculated from an
estimation of the number of participants needed in this
study before the application of the design effect (n =
202) and the number of clinicians (clusters) involved in
this research (n = 12). Based on these assumptions, 220
participants will need to be recruited.
Physical Activity Program
Participants will initially undertake a one-on-one session
with the exercise physiologist, which will involve a discus-
sion of each participant’s beliefs in his or her ability to be
physically active, physical activity preferences, outcome
expectations, goals, and strategies for using facilitators and
overcoming barriers to performing physical activity. The
topics for this discussion are based on the concepts (pre-
viously identified) within social cognitive theory that are
particularly relevant to health behaviour [19,20]. This is to
increase long-term adherence to physical activity.
Emphasis will be placed on exercise physiologists reg-
ularly counselling participants throughout the structured
physical activity sessions. The counselling topics will be
based on the constructs of social cognitive theory. Exer-
cise physiologists involved in this study will be trained
in the application of social cognitive theory to physical
activity uptake and adherence for survivors of prostate
cancer. Exercise physiologists will be provided with
checklists to ensure that they are regularly discussing
key factors, including setting goals, aligning activity with
outcome expectations, overcoming barriers and drawing
on facilitators.
Based on previous work with prostate cancer patients
[25], participants will undertake a 12-week program that
will include supervised physical activity sessions and
unsupervised physical activity. During the supervised
sessions, several participants may be exercising at the
same time. As participants will enter and leave the pro-
gram at varying times and will have different weekly
schedules, no attempt will be made to allocate partici-
pants to groups that will train in 12-week blocks. The
physical activity program will be tailored to suit the abil-
ity of each participant. Exercise physiologists will lead
two supervised sessions per week and will advise partici-
pants on what physical activity to undertake during
their one non-supervised session per week.
Each supervised session will last approximately 50
minutes and participants will be encouraged to socialise
following the sessions. The goal of the exercise training
is to achieve 150 minutes per week of moderate to
strenuous physical activity. Following the intervention,
participants will be provided with a physical activity pro-
gram by the exercise physiologist. The program will be
based on the preferences of the participant, in terms of
setting and type of exercise. The main goal of this train-
ing will be to maintain 150 minutes per week of moder-
ate to strenuous physical activity [26].
Supervised and unsupervised physical activity has been
included as both offer unique advantages. Supervised
programs have value because participants can be directly
observed (which may decrease risk of injury and also
improve adherence to physical activity) and unsuper-
vised programs are beneficial because of their potential
to increase long term adoption and maintenance of phy-
sical activity, especially if participants find cost effective
ways to incorporate physical activity into their daily rou-
tine [27]. Combining these approaches means that parti-
cipants receive guidance on physical activity techniques
and principles; have regular contact with, and encour-
agement from, the exercise physiologists and other par-
ticipants; and have opportunities to explore ways of
integrating physical activity into their lives.
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informed by Exercise Guidelines for Cancer Survivors of
the American College of Sports Medicine [28] and the
Australian Association for Exercise and Sport Science
[29], now known as Exercise and Sports Science Austra-
lia. The general program, which will be individualised
for each participant, will include three sessions per week
(two supervised and one unsupervised). Each session
will involve aerobic exercise, progressive resistance
training, balance, and flexibility exercises. The aerobic
exercise will include different modes of training (e.g.,
walking, jogging, cycling, cross training, rowing), for 20
minutes, at an intensity of 40% to 70% of predicted
heart maximum rates or 8 to 13 on the 15-point Borg
scale of perceived exertion [30,31]. Progressive resis-
tance training exercises (two to four compound exer-
cises for lower and upper body, one core strength
exercise) will be programmed using Thera-Bands and
progressing to machines and free weights. One set of 8
to 12 repetitions of each exercise will be performed in
the initial session, progressing to two sets of 8 to 12
repetitions of each exercise in subsequent sessions,
depending on the tolerance for exercise of each partici-
pant. In the unsupervised sessions, body weight and
Thera-band exercises will be prescribed for the progres-
sive resistance training component of the program. Bal-
ance exercises will include the one legged stand, tandem
stand and walk, and one legged semi squats. Flexibility
exercises will be prescribed for every major muscle
group.
Measures
Table 1 provides a summary of the constructs and their
measurement for this study.
Primary Outcome
Our primary outcome is the number of minutes of
moderate-and strenuous physical activity per week as
measured by an adapted version of the Leisure Time
Exercise Questionnaire [32]. In this questionnaire, parti-
cipants are asked to report the average weekly frequency
and duration with which they engaged in strenuous,
moderate, and light exercise over the past month. Con-
sistent with a change made to the questionnaire in a
study of colorectal cancer survivors [33], participants
were asked to report the average duration of time they
spent exercising at each intensity, in addition to the fre-
quency. In addition, some of the physical activities were
deleted from the instrument, because they were not
common activities in Australia (e.g., horseshoes, snow-
mobiling). The validity and reliability of the Leisure
Time Exercise Questionnaire compares favourably with
other physical activity questionnaires [34].
Secondary Outcome
The secondary outcome is the impact of the physical
activity program on the psychological well-being, quality
of life, and objective physical functioning of prostate
cancer survivors.
Quality of life
Q u a l i t yo fl i f ew i l lb em e a s u r e du s i n gac a n c e r - s p e c i f i c
instrument: the European Organization for Research
and Treatment of Cancer core quality of life question-
naire (EORTC QLQ-C30, version 3 [35]) and the pros-
tate tumour-specific module (EORTC QLQ-PR25 [36]).
The EORTC QLQ-C30 comprises both multi-item sub-
scales and single items, including five functional sub-
scales, three symptom subscales, a global health status
subscale, and six single items. The EORTC QLQ-PR25
is a 25-item questionnaire designed for use among
patients with localised prostate cancer, which has four
subscales: urinary symptoms, bowel symptoms, treat-
ment-related symptoms, and sexual functioning. The
EORTC QLQ-C30 has convergent and discriminant
validity, is responsive to change over time, and has
adequate internal consistency reliability [35]. The
EORTC QLQ-PR25 also has convergent and discrimi-
nant validity, and has adequate internal consistency
reliability [36].
Anxiety
Anxiety related to prostate cancer will be measured with
the Memorial Anxiety Scale for Prostate Cancer (MAX-
PC) [37]. This instrument has 18 items that represent
three subscales: prostate cancer anxiety, prostate specific
antigen anxiety, and fear of recurrence. The scale has
concurrent validity with established anxiety measures (e.
g., the anxiety subscale of the Hospital Anxiety and
Depression Scale [38]) and discriminant validity, as well
as sound internal consistency and test-retest reliability
[ 3 7 , 3 9 ] .T h eM A X - P Ca p p e a r st ob eam o r es e n s i t i v e
measure of cancer-related changes in anxiety than com-
parable measures [39].
Depression
Symptoms of depression will be assessed using the Cen-
tre for Epidemiological Studies Depression Inventory
(CES-D) [40]. This instrument has 20 items representing
symptoms associated with depression. The scale has
strong concurrent validity, with clinical and self-report
criteria, and sound construct validity [40]. The CES-D
has high internal consistency and acceptable test-retest
reliability. The authors of two recent reviews of depres-
sion and emotional distress measures for use with can-
cer patients strongly recommend the use of the CES-D
as a measure of depression [41,42].
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Objective physical functioning will be assessed using
standard measures: resting heart rate, blood pressure,
limb girth circumferences, 6 minute walk, sit to stand
(30 seconds), 1 repetition maximum strength test, and
Apley’s shoulder test [43]. These standard tests are sim-
ple, non-invasive, can be conducted with minimal equip-
ment and space, and have been validated for use with
older people and chronic disease groups [43].
Accelerometer Measures
Accelerometers will be worn by participants to quantify
physical activity objectively. The Actigraph GT3X accel-
erometer is a small matchbox-sized unit worn on a belt
on the hip that is a valid and reliable tool for measuring
physical activity among adults [44,45], and will be worn
for seven consecutive days. Movement count thresholds
based on established thresholds [45] will be used to cal-
culate the average time participants spent in moderate-
to vigorous-intensity physical activity. A specially
designed macro will be used to manage the data and for
examining physical activity outside of work hours for
employed individuals (data are recorded in ‘real time’
and are extractable for user-specified time periods). The
whole day will also be analysed to examine potential
compensation as a result of engaging in the physical
activity program.
All study participants will be asked to wear an acceler-
ometer for two 7-day periods. For participants in the
intervention condition, this will be in the week between
their fitness assessment session and commencement of
the 12 week physical activity program, and the week fol-
lowing completion of the exercise program (week 13).
For participants in the control condition, the two time
periods will be equivalent.
Participants will be asked to wear the accelerometer
on a belt around their waist over their right hip for a
seven day period, except when they are sleeping,
Table 1 Constructs and Measures
Construct Measure
Primary Outcome
Participation in Physical Activity Self-report using an adapted version of Godin and Shephard’s ‘Leisure Time Exercise
Questionnaire’ [32]
Secondary Outcomes
Objective Physical Functioning Resting heart rate, blood pressure, limb girth circumferences, 6 minute walk, sit to stand (30
seconds), 1 repetition maximum strength test, and Apley’s shoulder test [43].
Accelerometer measure The Actigraph GT3X accelerometer is a small matchbox-sized unit worn on a belt on the hip
that is a valid and reliable tool for measuring physical activity among adults [45,46], and will
be worn for eight consecutive days, before the intervention commences and during the final
week of the intervention.
Quality of Life European Organization for Research and Treatment of Cancer core quality of life
questionnaire (EORTC QLQ-C30, version 3 [35]) and the prostate tumour-specific module
(EORTC QLQ-PR25 [36]).
Anxiety Memorial Anxiety Scale for Prostate Cancer (MAX-PC) [37]
Depression Centre for Epidemiological Studies Depression Inventory (CES-D) [40].
Mediators
Task Self-Efficacy Participants rate the certainty with which they believe they can perform three physical tasks.
For each task, they rate the certainty with which they believe they can perform these tasks
for three time durations: 10, 20, and 30 minutes. Confidence will be measured on an 11-
point Likert scale, from 0 (not at all confident) to 100 (extremely confident). Measure based
on exercise and cancer research in which task self-efficacy was measured [48].
Barrier Self-Efficacy Participants rate the certainty with which they believe they can perform exercise when faced
with specific barriers. Items (barriers) from Bandura’s [47] self-efficacy to regulate exercise
instrument, with supplementary items from research on barriers to physical activity for
prostate cancer survivors [8] and research on barrier self efficacy and cancer survivors [48].
The 11-point Likert scale used in the measurement of task self-efficacy will also be used to
assess barrier self-efficacy.
Outcome Expectations Multidimensional Outcome Expectations for Exercise Scale (MOEES) [49].
Goals Participants indicate the number of days per week they intend to perform at least 30
minutes of exercise at a light, moderate or strenuous intensity now and in 12 weeks. Items
adapted from previous research using social cognitive theory constructs [51].
Socio-Cultural Factors (factors facilitating or impeding
participation in physical activity)
Participants asked perceptions of frequency with which each facilitator and barrier occurs
using a 5-point-Likert scale anchored by 0 (never) and 4 (always). Measure based on
guidelines for the development of scales to assess barriers to physical activity for cancer
patients [52] and content (i.e., facilitators and impediments) drawn from our prior work with
prostate cancer survivors [8].
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to begin data collection at 5:00 am the day after they
are received by participants (giving seven complete days
of recorded activity), and the epoch of integration is set
at 30 seconds. As the monitor records even slight
motion as a nonzero count, a sustained 20-minute per-
iod of zero counts is considered a non-wearing period,
and missing data will be imputed using the Expectation
Maximization (EM) algorithm as described previously
[46].
Participants who are unable to provide at least three
days with a minimum of six hours of data will be
excluded from this analysis as the accuracy of imputa-
tion is too imprecise. Accelerometer counts will be sum-
marised into time spent in each of four activity
intensities with thresholds for sedentary, light, moderate,
and vigorous activity intensity ranges of < 100, 101-
1951, 1952-5724, ≥ 5725 counts min
-1 respectively [45].
In addition, counts ≥ 1952/min will be converted to
their metabolic equivalent (MET; multiples of resting
metabolic rate in kcal kg h-1) and summed to create the
total “intensity weighted” minutes (i.e., MET-minutes) of
Moderate-Vigorous Physical Activity (MVPA) [45,46]
Mediators
The influence of individual and environmental media-
tors on participation in physical activity will be deter-
mined by the following measures.
Self-efficacy
Both task and barrier (self-regulatory) self-efficacy will be
measured using the methods Bandura [19,47] has pro-
posed. Task self-efficacy will be assessed through asking
participants to rate how confident they are that they can
perform three physical tasks: walking fast (light perspira-
tion), running, fast swimming or cycling hard, and doing
exercises with weights. For each task, they will be asked
the confidence with which they believe they can perform
these tasks for three time durations: 10, 20, and 30 min-
utes. Confidence will be measured on an 11-point Likert
scale, which is anchored by 0 (not at all confident) and
100 (extremely confident). Similar items have been
included in previous physical activity and cancer research
in which task self-efficacy was measured [48].
Barrier self efficacy will be assessed through asking
participants to rate how confident they are that they can
perform physical activity when faced with specific bar-
riers. The items (barriers) came from Bandura’s[ 4 7 ]
self-efficacy to regulate exercise instrument, with supple-
mentary items from research of physical activity for
prostate cancer survivors [8] and barrier self efficacy
and cancer patients [48]. The 11-point Likert scale used
in the measurement of task self-efficacy will also be
used to assess barrier self-efficacy.
Outcomes will be measured using the Multidimen-
sional Outcome Expectations for Exercise Scale
(MOEES) [49], which was designed for older adults. The
MOESS has 15 items that represent three sub-scales:
physical, social, and self-evaluative outcome expecta-
tions. Participants respond to each item on a 5-point
Likert scale from 1 (strongly disagree) to 5 (strongly
agree). The instrument’s construct validity has been
demonstrated through confirmatory factor analysis and
significant correlations with other constructs consistent
with the predictions inherent in social cognitive theory
[49,50]. The subscales of the MOEES have good internal
consistency reliability (a = .81 to .84) [49].
Goals
Goals will be measured using items adapted from pre-
vious physical activity research in which social cognitive
theory constructs were assessed [51]. Participants will be
asked to indicate the number of days per week they
intend to perform at least 30 minutes of exercise at a
light, moderate or strenuous intensity. At each question-
naire time point, participants will be asked their current
goals and their goals in 12 weeks.
Socio-structural factors
Socio-structural factors facilitating or impeding participa-
tion in physical activity will be measured using guidelines
for the development of scales to assess barriers to physi-
cal activity for cancer patients [52]. The content (i.e.,
facilitators and impediments) of the scale was drawn
from our prior work with prostate cancer survivors [8].
Participants will be asked their perceptions of the fre-
quency with which each facilitator and barrier occurs
using a 5-point Likert scale anchored by 0 (never) and 4
(always). These barriers and facilitators will be addressed
by the exercise physiologists throughout the intervention.
Procedures
Following ethical review and approval, we will invite
clinicians from three healthcare settings to participate in
the study. Clinicians will be randomly allocated to either
the intervention or control conditions and trained prior
to commencement of the study in the study’s objectives
and clinician requirements including the referral pro-
cess, requested dialogue and documentation completion.
Adherence to the intervention and control groups’ pro-
cesses, will be monitored weekly by the project manager.
Eligible patients will be identified by the health service
oncology nurses prior to presentation to either the pub-
lic health service outpatient clinic or private health ser-
vice rooms for their follow up consultation. During
clinic sessions, members of the research team will
approach eligible patients and introduce the study to the
patient, provide an information package and seek verbal
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Page 7 of 11approval to follow them up within 48 hours regarding
their interest in participating in the study.
Intervention condition
During the consultation, clinicians randomised to the
intervention arm will determine the patient’s eligibility
to be involved in the active exercise program and if
eligible, provide each patient with a referral (Figure 1)
to participate in the active exercise program and say “I
understand you have been given some information
about a research project that is being conducted. You
have been assigned to the exercise group. I recommend
that you take part. The project manager will call you
in a couple of days to see if you would like to take
part in the study. Your decision to take part in the
study will not affect your treatment or care in any
way”.
If the clinician does not believe that the patient is sui-
table for the study, they do not give the referral slip to
the patient, but complete a form to indicate reasons for
non-suitability (eg. co-morbidities; poor health status)
and say, “I understand you have been given some infor-
mation about a research project that is being conducted.
Due to your current state of health, I do not recommend
that you take part in this study. I will let the researchers
know that you cannot participate”.
Control condition
The control condition involves participants receiving
usual care from their clinicians regarding physical activ-
ity and, no referral to the active exercise program. Eligi-
ble patients will be approached by a team member to
discuss the project and if the patient agrees, will be
given the information package for the patient to take
home and consider participating the project.
Clinicians in the control group will say, “Iu n d e r s t a n d
you have been given some information about a research
project that is being conducted. Although you have not
been assigned to the exercise group, I recommend that
you take part in the study. The project manager will call
you in a couple of days to see if you would like to take
part in the study. Your decision to take part in the study
will not affect your treatment or care in any way”.
If the clinician does not believe that the patient is sui-
table for the study, they complete a form to indicate
reasons for non-suitability, and say the following:
“I understand you have been given some information
about a research project that is being conducted. Due to
your current state of health, I do not recommend that
you take part in this study. I will let the researchers
know that you cannot participate”.
To ensure the integrity of the trial’s procedures, each
of the clinicians and health service oncology nurses will
undergo specific training and quality assurance assess-
ments throughout the recruitment phase of the study.
Clinicians in both the intervention and control groups
will discuss involvement in the project and provide a
recommendation to participate if s/he considers it is fea-
sible for the patient to participate. If the clinician deter-
mines the patient should not participate, s/he will
complete the Reason for Non-Suitability Form and
record the reason for non-participation, for example,
pre-existing medical conditions, and the patient will be
advised accordingly.
If the patient is eligible and has agreed to be followed
up, the project manager will telephone them within 48
hours to determine the patient’s interest in participating,
answer any questions he may have and if happy to parti-
cipate, request return of the signed consent form and
baseline questionnaires. Once a consent form has been
returned, the project manager will arrange a time for
the participant’s first fitness assessment. Figure 2 shows
the recruitment and data collection time points for the
study.
Data collection for all measures and for participants in
both conditions will occur at baseline and 12 weeks (on
completion of the intervention). Participants in the
intervention condition will be referred to the exercise
program, whereas those in the control condition will
receive usual advice about exercise from their clinician.
Data collection will continue for participants in both
Patient’s name Date of referral
Consent
__/__/__
The program is free of charge and 
provided by Deakin University
I will arrange for you  to take part in  
a 12 week exercise program, 
supervised by exercise physiologists
at the YMCA
This program includes 
2 YMCA sessions each week and 
1 home-based session
Doctor’s signature
Doctor’s name
Figure 1 Referral slip provided to participants by clinicians in
the intervention group.
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Page 8 of 11conditions and for all measures except those of objective
physical functioning at 6 months and 12 months.
For those in the intervention group, over the 12 week
physical activity period, three morning and three after-
noon sessions between Monday and Friday will be avail-
able for participants to attend. On commencement of
the program, the project manager will provide a timeta-
ble of sessions that is convenient to the participant. The
exercise physiologist will contact the participant 24
hours prior to their first physical activity session each
week and remind them of their session times for the
week. If the participant cannot be contacted, the exer-
cise physiologist will contact the participant the day of
their physical activity session to remind them of their
session time. After two failed telephone attempts and if
the participant does not attend the session, the partici-
pant will be declared ‘absent’ for the session. The total
number of sessions attended by the participants will be
recorded.
Analysis
To address the primary aim of this study, we will con-
duct three main tests. To assess the impact of the inter-
vention, we will perform an analysis of covariance
(ANCOVA) on the post-intervention (12-week) physical
activity levels of the participants in the two conditions,
with their baseline scores as a covariate [53]. To deter-
mine the sustainability of the physical activity levels at 6
and 12 months, we will perform two ANCOVA on
post-intervention (6 and 12 months, respectively) physi-
cal activity levels of the participants in the two condi-
tions, with baseline scores as covariates.
To examine the data on the first of the secondary
aims (determining the effect of the clinician referral and
the physical activity program on psychological well-
being, quality of life, and objective physical functioning)
we will use the same analytical strategies as for the pri-
mary aim (ANCOVA with baseline scores as a covari-
ates [53]). For this analysis, the dependent variables will
be the subscales of the quality of life, anxiety, and
depression measures, as well as the separate measures of
objective physical functioning. The immediate effects of
the intervention will be assessed using the 12-week data.
The sustainability of the effects of the intervention on
quality of life, anxiety, and depression will be assessed at
6 and 12 months.
To address the final aim, we will use path analyses to
test for possible mediation of the intervention effect on
level of physical activity based on the Baron and Kenny
[54] approach. We will only test the components of
SCT as possible mediators if they were affected by the
intervention (i.e., group assignment) and associated with
follow-up participation in physical activity. This
approach requires that the outcome (i.e., participation in
physical activity) be regressed on the proposed media-
tors (i.e. SCT components) and the intervention (i.e.,
group assignment coded as “0"= control and “1"= inter-
vention). Mediation is present when the proposed med-
iator maintains a significant relationship with the
outcome whereas group assignment does not. For the
path analysis, we will adjust for the same variables as in
the main analyses.
For all analyses, we will employ the intention-to-treat
principle for all participants with available data at post
intervention and follow-up.
Discussion
To the best of the authors’ knowledge, this trial is the
first to consider the efficacy of clinician referrals to a
physical activity program to increase physical activity
levels among cancer survivors. Although there is an
expanding evidence that provides strong support for pro-
moting physical activity among survivors of prostate can-
cer [5], substantial work has yet to be undertaken on how
this research could be implemented into clinical practice.
This trial also has a strong emphasis on behaviour
change and the mechanisms through which this change
occurs. This addresses a limitation of previous research,
as few randomised controlled trials of cancer survivors,
or indeed other population groups, have examined the
effects of a physical activity intervention on potential
mediators of behaviour change and physical activity
adherence using a theoretical model. In applying social
cognitive theory, the intervention design addresses key
constructs in social cognitive theory and examines if
these factors change as a result of the intervention and
if this change, in turn, explains change in physical activ-
ity participation. This investigation provides data that
will assist in the design of physical activity trials that
have behaviour change as a primary aim and outcome.
Randomisation of Urologists
Si f Pt t C P t f Survivors ofP rostate Cancer Presentf or 
Follow up Consultation
Control Group Control Group Intervention: Physical Activity Group Intervention: Physical Activity Group
Recruitment Recruitment Recruitment
Baseline questionnaire
Recruitment
Baseline session: Fitness Assessment & 
Physical Activity (PA) Measures
Baseline session: Fitness Assessment & 
Physical Activity (PA) Measures
12 week program : 2 gym sessions and 
1 home session each week
12-week follow up fitness assessment and questionnaire
6 f ii 6-month follow up questionnaire
12-month follow up telephone questionnaire
Figure 2 Recruitment and data collection procedures.
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Page 9 of 11In the present study, we investigate one way in which
the physical activity levels of prostate cancer survivors
could be increased, to improve health outcomes while
incorporating social and cognitive mechanisms that may
contribute to desired outcomes. Findings from this
research may have implications for the treatment of not
only prostate cancer survivors but also other cancer sur-
vivors and those with other chronic health conditions.
Acknowledgements
This study was funded by the Australian Research Council and the Prostate
Cancer Foundation of Australia, with in-kind support from YMCA Victoria,
Eastern Health, Epworth Healthcare, North Eastern Metropolitan Integrated
Cancer Service and Peter MacCallum Cancer Centre. Kerry S. Courneya is
supported by the Canada Research Chairs Program.
Author details
1Faculty of Health, Deakin University, 221 Burwood Highway, Burwood,
Victoria 3125, Australia.
2Behavioural Medicine Laboratory, Faculty of Physical
Education and Recreation, E-488 Van Vliet Center, University of Alberta,
Edmonton, Alberta T6G 2H9, Canada.
3School of Sport & Exercise Science,
Victoria University, PO Box 14428, Melbourne, Victoria 8001, Australia.
Authors’ contributions
PML and MC developed the study concept and initiated the project. PML,
MC, JS, KC, CJG, MB, SB, and BK provided significant input into the
development of the protocol. Each of the authors have contributed, read
and approved the final manuscript. The investigators will be involved in the
steering committee, implement the protocol and/or oversee data collection.
Competing interests
The authors declare that they have no competing interests.
Received: 6 May 2011 Accepted: 13 June 2011 Published: 13 June 2011
References
1. Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin DM: GLOBOCAN 2008,
Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10
[Internet]. Lyon, France: International Agency for Research on Cancer; 2010.
2. Australian Institute of Health and Welfare: Cancer in Australia: An
overview. Cancer series no. 60. Cat. no. CAN 56. Canberra, Australia: AIHW;
2010.
3. Australian Institute of Health and Welfare: Cancer in Australia: In Brief
2010. Canberra: AIHW; 2010.
4. Speck RM, Courneya KS, Mâsse LC, Duval S, Schmitz KH: An update of
controlled physical activity trials in cancer survivors: A systematic review
and meta-analysis. Journal of Cancer Survivorship 2010, 4:87-100.
5. Thorsen L, Courneya KS, Stevinson C, Fosså SD: A systematic review of
physical activity in prostate cancer survivors: outcomes, prevalence, and
determinants. Support Care Cancer 2008, 16:987-997.
6. Galvão DA, Spry NA, Taaffe DR, Newton RU, Stanley J, Shannon T,
Rowling C, Prince R: Changes in muscle, fat and bone mass after 36
weeks of maximal androgen blockade for prostate cancer. BJU
International 2008, , 102: 44-47.
7. Humpel N, Iverson DC: Depression and quality of life in cancer survivors:
Is there a relationship with physical activity? International Journal of
Behavioral Nutrition and Physical Activity 2007, 4:65.
8. Craike M, Livingston PM, Botti M: An exploratory study of the factors that
Influence physical activity for prostate cancer survivors. Support Care
Cancer .
9. Livingston PM, Wood CA, Butler M, Oh J, Keefe JE, Taylor HR: General
practitioners are the most important conveyors of information to their
patients regarding diabetic retinopathy. Diabetes Care 1998, 21(2):324-325.
10. Wisse W, Rookhuizen MB, de Kruif MD, van Rossum J, Jordans I, ten Cate H,
van Loon LJ, Meesters EW: Prescription of physical activity is not
sufficient to change sedentary behavior and improve glycemic control
in type 2 diabetes patients. Diabetes Res Clin Prac 2010, 88(2):e10-13.
11. Sørensen JB, Kragstrup J, Skovgaard T, Puggaard L: Exercise on
prescription: a randomized study on the effect of counseling vs
counseling and supervised exercise. Scandinavian Journal of Medicine &
Science in Sports 2008, 18:288-297.
12. Leijon ME, Bendtsen P, Nilsen P, Festin K, Ståhle A: Does a physical activity
referral scheme improve the physical activity among routine primary
health care patients? Scandinavian Journal of Medicine & Science in Sports
2009, 19:627-636.
13. Kallings LV, Leijon ME, Hellénius M-L, Ståhle A: Physical activity on
prescription in primary health care: A follow-up of physical activity level
and quality of life. Scandinavian Journal of Medicine & Science in Sports
2008, 18:154-161.
14. Sørensen JB, Skovgaard T, Puggaard L: Exercise on prescription in general
practice: A systematic review. Scandinavian Journal of Primary Health Care
2006, 24(2):69-74.
15. Michie S: Designing and implementing behaviour change interventions
to improve population health. J Health Serv Res Policy 2008, 13:64-69.
16. Bandura A: Social foundations of thought and action: A social cognitive
theory. Englewood Cliffs, NJ: Prentice-Hall; 1986.
17. Ayotte BJ, Margrett JA, Hicks-Patrick J: Physical activity in middle-aged
and young-old adults: The roles of self-efficacy, barriers, outcome
expectancies, self-regulatory behaviors and social support. Journal of
Health Psychology 2010, 15:173-185.
18. Rogers LQ, Shah P, Dunnington G, Greive A, Shanmugham A, Dawson B,
Courneya KS: Social cognitive theory and physical activity during breast
cancer treatment. Oncology Nursing Forum 2005, 32:807-815.
19. Bandura A: Self-efficacy: The exercise of control. New York: W. H. Freeman
and Company; 1997.
20. Bandura A: Health promotion by social cognitive means. Health Education
& Behavior 2004, 31:143-164.
21. McAuley E, Mihalko SL: Measuring exercise-related self-efficacy. In
Advances in sport and exercise psychology measurement. Edited by: Duda JL.
Morgantown, WV: Fitness Information Technology; 1998:371-390.
22. Livingston PM, White V, Hayman J, Maunsell E, Dunn S, Hill D: The
psychological impact of a specialist referral and telephone intervention
on male cancer patients. Psychooncology 2010, 19:617-625.
23. Underwood M, Barnett A, Hajioff S: Cluster randomization: A trap for the
unwary. British Journal of General Practice 1998, 48:1089-1090.
24. Demark-Wahnefried W, Clipp EC, Lipkus IM, Lobach D, Clutter Snyder D,
Sloane R, Peterson B, Macri JM, Rock CL, McBride CM, Kraus WE: Main
outcomes of the FRESH START trial: A sequentially tailored, diet and
exercise mailed print intervention among breast and prostate cancer
survivors. Journal of Clinical Oncology 2007, 25:2709-2718.
25. Segal RJ, Reid RD, Courneya KS, Malone SC, Parliament MB, Scott CG,
Venner PM, Quinney HA, Jones LW, Slovinec D’Angelo ME, Wells GA:
Resistance exercise in men receiving androgen deprivation therapy for
prostate cancer. Journal of Clinical Oncology 2003, 21:1653-1659.
26. Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galva˜o DA,
Pinto BM, Irwin ML, Wolin KY, Segal RJ, Lucia A, Schneider CM, von
Gruenigen VE, Schwartz AL: American College of Sports Medicine
Roundtable on Exercise Guidelines for Cancer Survivors. Medicine &
Science in Sports and Exercise 2010, 42(7):1409-1426.
27. King AC, Haskell WL, Barr Taylor C, Kraemer HC, DeBusk RF: Group-vs
home-based exercise training in healthy older men and women: A
community-based clinical trial. Journal of the American Medical Association
1991, 266:1535-1542.
28. Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvão DA,
Pinto BM, Irwin ML, Wolin KY, Segal RJ, Lucia A, Schneider CM, von
Gruenigen VE, Schwartz AL: American College of Sports Medicine
roundtable on exercise guidelines for cancer survivors. Medicine & Science
in Sports & Exercise 2009, 42:1409-1426.
29. Hayes SC, Spence RR, Galvão DA, Newton RU: Australian Association for
Exercise and Sport Science position stand: Optimising cancer outcomes
through exercise. Journal of Science and Medicine in Sport 2009, 12:428-434.
30. Borg G: Perceived exertion as an indicator of somatic stress. Scandinavian
journal of Rehabilitation Medicine 1970, 2:92-98.
31. Borg G: Psychophysical bases of perceived exertion. Medicine & Science in
Sports & Exercise 1982, 14:377-381.
32. Godin G, Shephard RJ: A simple method to assess exercise behaviour in
the community. Canadian Journal of Applied Sport Science 1985,
10(3):141-146.
Livingston et al. BMC Cancer 2011, 11:237
http://www.biomedcentral.com/1471-2407/11/237
Page 10 of 1133. Courneya KS, Friedenreich CM, Quinney HA, Fields ALA, Jones LW,
Vallance JKH, Fairey AS: A longitudinal study of exercise barriers in
colorectal cancer survivors participating in a randomized controlled trial.
Annals of Behavioral Medicine 2005, 29:147-153.
34. Jacobs DR, Ainsworth BE, Hartman TJ, Leon AS: A simultaneous evaluation
of 10 commonly used physical activity questionnaires. Medicine & Science
in Sports & Exercise 1993, 25:81-91.
35. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ,
Filiberti A, Flechtner H, Fleishman SB, de Haes JCJM, Kaasa S, Klee M,
Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F: The
European Organization for Research and Treatment of Cancer QLQ-C30:
A quality-of-life instrument for use in international clinical trials in
oncology. Journal of the National Cancer Institute 1993, 85:365-376.
36. Borghede G, Sullivan M: Measurement of quality of life in localized
prostatic cancer patients treated with radiotherapy. Development of a
prostate cancer-specific module supplementing the EORTC QLQ-C30.
Quality of Life Research 1996, 5(2):212-222.
37. Roth AJ, Rosenfeld B, Kornblith AB, Gibson C, Scher HI, Curley-Smart T,
Holland JC, Breitbart W: The Memorial Anxiety Scale for Prostate Cancer:
Validation of a new scale to measure anxiety in men with prostate
cancer. Cancer 2003, 97:2910-2918.
38. Zigmund AS, Snaith RP: The Hospital Anxiety and Depression Scale. Acta
Psychiatrica Scandinavica 1983, 67:361-370.
39. Roth AJ, Nelson CJ, Rosenfeld B, Warshowski A, O’Shea N, Scher HI,
Holland JC, Slovin S, Curley-Smart T, Reynolds T, Breitbart W: Assessing
anxiety in men with prostate cancer: Further data on the reliability and
validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC).
Psychosomatics 2006, 47:340-347.
40. Radloff LS: The CES-D scale: A self-Report depression scale for research
in the general population. Applied Psychological Measurement 1977,
1:385-401.
41. Luckett T, Butow PN, King MT, Oguchi M, Heading G, Hackl NA, Rankin N,
Price MA: A review and recommendations for optimal outcome
measures of anxiety, depression and general distress in studies
evaluating psychosocial interventions for English-speaking adults with
heterogeneous cancer diagnoses. Support Care Cancer 2010, 18:1241-1262.
42. Vodermaier A, Linden W, Siu C: Screening for emotional distress in cancer
patients: A systematic review of assessment instruments. Journal of the
National Cancer Institute 2009, 101:1464-1488.
43. American College of Sports Medicine: ACSM’s resource manual for
guidelines for exercise testing and prescription. Philadelphia: Lippincott
Williams & Wilkins;, 6 2010.
44. Sirard JR, Melanson EL, Li L, Freedson PS: Field evaluation of the computer
science and applications, including physical activity monitor. Med Sci
Sports Exerc 1999, 32:695-700.
45. Freedson PS, Melanson E, Sirard J: Calibration of the computer science
and applications, including accelerometer. Med Sci Sports Exerc 1998,
30:777-781.
46. Catellier DJ, Hannan PJ, Murray DM, Addy CL, Conway TL, Yang S, Rice JC:
Imputation of missing data when measuring physical activity by
accelerometry. Medicine and Science in Sports and Exercise 2005, 37(11
(supplement)):S555-562.
47. Bandura A: Guide for constructing self-efficacy scales. In Self-efficacy beliefs
of adolescents. Edited by: Pajares F, Urden T. Charlotte, NC: Information Age
Publishing; 2006:307-337.
48. Rogers LQ, Courneya KS, Verhulst S, Markwell S, Lanzotti V, Shah P: Exercise
barrier and task self-efficacy in breast cancer patients during treatment.
Support Care Cancer 2006, 14:84-90.
49. Wójcicki TR, White SM, McAuley E: Assessing outcome expectations in
older adults: The Multidimensional Outcome Expectations for Exercise
Scale. Journal of Gerontology: Psychological Sciences 2009, 64(1):33-40.
50. McAuley E, Motl RW, White SM, Wójcicki TR: Validation of the
Multidimensional Outcome Expectations for Exercise Scale in
ambulatory, symptom-free persons with multiple sclerosis. Archives of
Physical Medicine and Rehabilitation 2010, 91:100-105.
51. Doerksen SE, Umstattd MR, McAuley E: Social cognitive determinants of
moderate and vigorous physical activity in college freshmen. Journal of
Applied Social Psychology 2009, 39:1201-1213.
52. Brawley LR, Culos-Reed SN, Angove J, Hoffman-Goetz L: Understanding the
barriers to physical activity for cancer patients: Review and
recommendations. Journal of Psychosocial Oncology 2002, 20(4):1-21.
53. Huck S, McLean R: Using a repeated measures ANOVA to analyze the
data from a pretest-posttest design: A potentially confusing task.
Psychological Bulletin 1975, 82:311-318.
54. Baron RM, Kenny DA: The moderator-mediator variable distinction in
social psychological research: conceptual, strategic, and statistical
considerations. Journal of Personality and Social Psychology 1986,
51:1173-1182.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2407/11/237/prepub
doi:10.1186/1471-2407-11-237
Cite this article as: Livingston et al.: Efficacy of a referral and physical
activity program for survivors of prostate cancer [ENGAGE]: Rationale
and design for a cluster randomised controlled trial. BMC Cancer 2011
11:237.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Livingston et al. BMC Cancer 2011, 11:237
http://www.biomedcentral.com/1471-2407/11/237
Page 11 of 11